Skip to main content
Livermore
Livermore
ZHEN

Microbot Medical Inc.

MBOT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000883975

No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Microbot Medical Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of MBOT: Q4 2021 compared with Q1 2022
MeasureQ4 2021Of which not filed for Q1 2022Q1 2022Change
Holders27127+1
Shares812.9K100.0K741.3K+28.4K (+4.0%)
Value$6.10M$750.0K$4.65M−$700.0K (−13.1%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held Microbot Medical Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to MBOT in Q1 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC14,847$93.0K0.00%
Millennium Management LLC13,997$88.0K0.00%
Blueshift Asset Management, LLC12,841$81.0K0.01%
Cetera Advisor Networks LLC12,448$78.0K0.00%
Tower Research Capital LLC (TRC)1,112$7.00K0.00%
FMR LLC1$00.00%

Sold out (5)

Institutions that held Microbot Medical Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of MBOT in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Virtu Financial LLC12,622$95.0K
Investment Management Associates Inc10,000$75.0K
Rinkey Investments500$3.00K
CoreCap Advisors, LLC50$1.00K
IronBridge Private Wealth, LLC25$0

Not filed for Q1 2022 yet (1)

Institutions that held Microbot Medical Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MBOT in Q4 2021 that haven't filed for Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
AlphaCentric Advisors LLC100,000$750.0K